Association between maternal organophosphate flame retardants (OPFRs) metabolite levels during pregnancy and internalizing and externalizing behaviors in children at 2-5 years
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Organophosphorus flame retardants (OPFRs) metabolites are frequently detected in human samples. Their structural similarity to polybrominated diphenyl ethers raises concerns about potential neurotoxicity. Animal and limited human studies suggest prenatal exposure to OPFRs may affect offsprings’ neurobehavioral problems.
Objectives
We investigated the association between maternal OPFRs exposure and neurobehavioral problems in children aged two to five years from the South African Drakenstein Child Health Study (N=705).
Methods
We measured urinary metabolites of OPFRs, bis(1,3-dichloro-2-propyl) phosphate (BDCPP) and diphenyl phosphate (DPHP) during the 2 nd trimester of pregnancy or at birth, using a targeted multiclass assay. Childhood behaviors were repeatedly assessed at 24, 42 and 60 months using the Child Behavior Checklist (CBCL). After natural log transformation of metabolite concentrations, we used linear regression to analyze the association between BDCPP and DPHP levels and internalizing/externalizing behaviors t-scores, adjusting for maternal age, body mass index, ancestry, and socioeconomic status.
Results
At 24 months, each standard deviation (SD) increase in log-BDCPP levels was associated with higher externalizing (1.26, 95% CI: 0.30, 2.21) and internalizing (1.14, 95% CI: 0.02, 2.25) subscores. Similarly, one SD increase in log-DPHP was associated with higher externalizing (+1.19, 95% CI: 0.23, 2.16) and internalizing (1.00, 95% CI: −0.12, 2.13) subscores. Only DPHP levels were associated with internalizing subscores at 60 months.
Conclusion
We observed a positive association between prenatal metabolite levels of OPFRs and neurobehavioral problems among children at age two, raising concerns about prenatal chemical exposures and awareness of developing interventions to promote healthier developmental outcomes for children.
